YolTech Therapeutics

Private

ShanghaiHealthcare & Life Scienceshttps://www.yoltx.com/

Last Round

Series C

May 28, 2026

Total Funding Raised

$147M

Company Overview

YolTech Therapeutics is a biotechnology company that develops in vivo gene-editing therapies for serious genetic, metabolic, and cardiovascular diseases using proprietary CRISPR-Cas and lipid nanoparticle delivery platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

gene editingin vivo therapyCRISPRgene therapybase editinggenetic medicinelipid nanoparticleLNPgenomic medicinebiotechnologydrug discoverymetagenomicsclinical-stage biotechprecision medicinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

YolTech Therapeutics Comps

Public and private peers based on sector, stage, and business model.

YolTech Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

YolTech Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	May 28, 2026
Series B	Sep 11, 2025
Series A Extension	Nov 1, 2023
Series A	Aug 1, 2022

View all Funding Rounds

YolTech Therapeutics Investors

Notable investors and investment history

YolTech Therapeutics investors
Investor	Rounds
Loyal Valley Capital	Series C
Unity Ventures	Series A
险峰K2VC	Series C, Series A
Decheng Capital	Series B, Series A Extension

View all Investors

YolTech Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

YolTech Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about YolTech Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Employee Range1

Year Founded2021

Last FundingMay 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.